Thakkar Radhika, Rangraze Imran R, Gabhale Sanjay D, Ram Jagjeewan, Devarapalli Nagaraju, Kudagi Vishal S, Tiwari Rahul
Eastman Institute for Oral Health, University of Rochester, Rochester, New York, United States.
Department of Internal Medicine, RAK Medical and Health Sciences University, Al Juwais, Al Qusaidat, Ras al Khaimah, United Arab Emirates.
J Pharm Bioallied Sci. 2024 Feb;16(Suppl 1):S372-S375. doi: 10.4103/jpbs.jpbs_595_23. Epub 2024 Feb 29.
COVID-19, the Ecumenical Pandemic that hit Wuhan, Hubei Province, China, in 2019 has instigated an emergency situation all over the globe. Current scientific corroborations highlighted the role of zoonotic cross-over species transmission for the spread of the deadly virus SARSCoV2. The proposition of ABO blood grouping to susceptibility for various infectious diseases has been documented in the past since blood group antigens constitute polymorphic traits that are inherited among humans, therefore are frequent targets in epidemiological studies.
To correlate the ABO blood group susceptibility to disease severity in COVID-19-positive cases among Indian populations.
Association of ABO blood group patterns to disease severity in COVID-19-positive cases.
A cross-sectional, observational study design was conducted among 700 confirmed COVID-19-positive cases admitted to the tertiary health care center in Maharashtra, India. The data collected were subjected to statistical analysis.
Blood group 'A' positive was frequent (40%) in severe COVID-19 (E group) disease, and 'O' positive blood group was frequent in moderate COVID-19 disease (34.62%).
ABO Blood grouping can be used as one of the efficient biomarker for COVID-19, thereby providing a new platform for therapeutic applications in the field of research.
2019年袭击中国湖北省武汉市的全球大流行疾病——新型冠状病毒肺炎引发了全球紧急情况。目前的科学证据强调了人畜共患跨物种传播在致命病毒严重急性呼吸综合征冠状病毒2传播中的作用。过去已有文献记载ABO血型与多种传染病易感性的关系,因为血型抗原构成人类遗传的多态性特征,因此是流行病学研究的常见目标。
在印度人群中,将ABO血型易感性与新型冠状病毒肺炎阳性病例的疾病严重程度相关联。
ABO血型模式与新型冠状病毒肺炎阳性病例疾病严重程度的关联。
对印度马哈拉施特拉邦一家三级医疗中心收治的700例确诊新型冠状病毒肺炎阳性病例进行横断面观察性研究设计。对收集到的数据进行统计分析。
在重症新型冠状病毒肺炎(E组)病例中,A型阳性血型较为常见(40%),在中度新型冠状病毒肺炎病例中,O型阳性血型较为常见(34.62%)。
ABO血型可作为新型冠状病毒肺炎的有效生物标志物之一,从而为该研究领域的治疗应用提供一个新平台。